NASDAQ:IMRAPassage Bio Stock Price, Forecast & News

$15.75

0.00 (0.00 %)

(As of 04/5/2020 11:59 AM ET)

Add

Compare

Today's Range

$15.75

Now: $15.75▼

$16.13

50-Day Range N/A

52-Week Range

$13.40

Now: $15.75▼

$17.50

Volume15,009 shs

Average Volume35,892 shs

Market Capitalization$261.14 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Imara, Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. It develops IMR-687, which is an oral, once-a-day therapeutic for the treatment of sickle cell disease and b-thalassemia. The company was founded in 2016 and is headquartered in Boston, Massachusetts.

Beat the Market (BTM) Rank^™

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Passage Bio.

2.5 Community Rank

Outperform Votes
Passage Bio has received 2 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Passage Bio has received 2 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Passage Bio has received 50.00% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Passage Bio and other stocks. Vote “Outperform” if you believe IMRA will outperform the S&P 500 over the long term. Vote “Underperform” if you believe IMRA will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Passage Bio does not currently pay a dividend.
Dividend Growth
Passage Bio does not have a long track record of dividend growth.

3.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Passage Bio insiders have bought more of their company's stock than they have sold. Specifically, they have bought $7,750,000.00 in company stock and sold $0.00 in company stock.

0.0 Earnings and Valuation

Overall Beat the Market Rank^™

1.10 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Pharmaceutical preparations

Sub-IndustryN/A

SectorMedical

Current SymbolNASDAQ:IMRA

Previous Symbol

CUSIPN/A

CIKN/A

Webhttp://www.imaratx.com/

Phone617-206-2020

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Employees16

Outstanding Shares16,580,000

Market Cap$261.14 million

Next Earnings DateN/A

OptionableNot Optionable

Receive IMRA News and Ratings via Email

Sign-up to receive the latest news and ratings for IMRA and its competitors with MarketBeat's FREE daily newsletter.

Passage Bio (NASDAQ:IMRA) Frequently Asked Questions

Has Passage Bio been receiving favorable news coverage?

Media coverage about IMRA stock has trended very negative recently, InfoTrie reports. The research group rates the sentiment of media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Passage Bio earned a news sentiment score of -3.3 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the next several days. View the latest news aboutPassage Bio.

Who are some of Passage Bio's key competitors?

Some companies that are related to Passage Bio include TG Therapeutics (TGTX), Phibro Animal Health (PAHC), Enanta Pharmaceuticals (ENTA), Y-mAbs Therapeutics (YMAB), NextCure (NXTC), I-Mab (ARQT), Kiniksa Pharmaceuticals (KNSA), Madrigal Pharmaceuticals (MDGL), Akebia Therapeutics (AKBA), Amneal Pharmaceuticals (AMRX), Esperion Therapeutics (ESPR), Supernus Pharmaceuticals (SUPN), Aimmune Therapeutics (AIMT), Phoenix Tree (IMAB) and Phathom Pharmaceuticals (PHAT).

Who are Passage Bio's key executives?

Passage Bio's management team includes the following people:

Dr. Rahul D. Ballal Ph.D., Pres, CEO & Director (Age 42)
Mr. Michael P. Gray CPA, M.B.A., MBA, CPA, CFO & COO (Age 49)
Dr. Willem H. Scheele M.D., Chief Medical Officer (Age 59)
Dr. James G. McArthur, Founder & Director (Age 58)
Mr. Frank Waligora, VP of Technical Operations

When did Passage Bio IPO?

(IMRA) raised $76 million in an IPO on Thursday, March 12th 2020. The company issued 4,500,000 shares at a price of $16.00-$18.00 per share. Morgan Stanley, Citigroup and SVB Leerink served as the underwriters for the IPO.

What is Passage Bio's stock symbol?

Passage Bio trades on the NASDAQ under the ticker symbol "IMRA."

When does the company's quiet period expire?

Passage Bio's quiet period expires on Tuesday, April 21st. Passage Bio had issued 4,700,000 shares in its IPO on March 12th. The total size of the offering was $75,200,000 based on an initial share price of $16.00. During the company's quiet period, underwriters and any insiders involved in the IPO are prevented from issuing any earnings forecasts or research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the end of the company's quiet period, it's expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

How do I buy shares of Passage Bio?

Shares of IMRA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Passage Bio's stock price today?

One share of IMRA stock can currently be purchased for approximately $15.75.

How big of a company is Passage Bio?

Passage Bio has a market capitalization of $261.14 million. Passage Bio employs 16 workers across the globe. View additional information about Passage Bio.

What is Passage Bio's official website?

The official website for Passage Bio is http://www.imaratx.com/.

How can I contact Passage Bio?

Passage Bio's mailing address is 116 HUNTINGTON AVENUE 6TH FLOOR, BOSTON MA, 02116. The company can be reached via phone at 617-206-2020 or via email at [email protected]

This page was last updated on 4/5/2020 by MarketBeat.com Staff